Edition:
United Kingdom

Kala Pharmaceuticals Inc (KALA.OQ)

KALA.OQ on NASDAQ Stock Exchange Global Select Market

9.86USD
17 Oct 2018
Change (% chg)

-- (--)
Prev Close
$9.86
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
83,866
52-wk High
$22.02
52-wk Low
$7.60

Chart for

About

Kala Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of therapeutics through its nanoparticle-based Mucus Penetrating Particles, or MPP, technology. The Company’s initial focus is on the treatment of eye diseases. The Company’s product candidate includes KPI-121 1%, KPI-121... (more)

Overall

Beta: --
Market Cap(Mil.): $547.77
Shares Outstanding(Mil.): 24.23
Dividend: --
Yield (%): --

Financials

  KALA.OQ Industry Sector
P/E (TTM): -- 85.83 33.69
EPS (TTM): -1.67 -- --
ROI: -- 0.58 14.30
ROE: -- 1.62 16.03

FDA approves Kala Pharma's eye pain drug

The U.S. Food and Drug Administration on Thursday approved Kala Pharmaceuticals Inc's treatment for reducing inflammation and pain following an eye surgery.

23 Aug 2018

U.S. FDA approves Kala Pharma's eye pain drug

Aug 23 The U.S. Food and Drug Administration on Thursday approved Kala Pharmaceuticals Inc's treatment for reducing inflammation and pain following an eye surgery.

23 Aug 2018

BRIEF-Kala Pharmaceuticals Reports Q1 Loss Per Share Of $0.46

* KALA PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

10 May 2018

BRIEF-Kala Pharmaceuticals - PDUFA Target Action Date For Inveltys Is August 24, 2018

* KALA PHARMACEUTICALS INC - PDUFA TARGET ACTION DATE FOR INVELTYS IS AUGUST 24, 2018 Source text for Eikon: Further company coverage:

09 May 2018

Earnings vs. Estimates